The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Corteva Inc
LSE:0A1W
|
US |
|
K
|
Kawan Food Bhd
KLSE:BKAWAN
|
MY |
|
T
|
Tectona Ltd
TASE:TECT
|
IL |
|
E
|
Enlivex Ltd
F:1BT
|
IL |
|
Activeops PLC
LSE:AOM
|
UK |
|
I
|
ITCenGlobal Co Ltd
KOSDAQ:124500
|
KR |
|
M
|
Merck KGaA
SWB:MRK
|
DE |
|
H
|
Huadian Power International Corp Ltd
XHAM:SHX
|
CN |
|
Akebia Therapeutics Inc
NASDAQ:AKBA
|
US |
|
H
|
H World Group Ltd
SWB:CL4A
|
CN |
|
A
|
Anglo Philippine Holdings Corp
XPHS:APO
|
PH |
|
Tata Consultancy Services Ltd
NSE:TCS
|
IN |
|
Philip Morris International Inc
SIX:PMI
|
US |
|
F5 Inc
XETRA:FFV
|
US |
|
A
|
Archer-Daniels-Midland Co
F:ADM
|
US |
|
I
|
Informa PLC
F:IEA
|
UK |
|
N
|
Nexon Co Ltd
OTC:NEXOF
|
JP |
|
China Overseas Land & Investment Ltd
HKEX:688
|
HK |
|
Siemens AG
MIL:1SIE
|
DE |
|
D
|
Dentsu Group Inc
DUS:DEN
|
JP |
|
F
|
FMC Corp
F:FMQ
|
US |
|
Brainsway Ltd
OTC:BRSYF
|
IL |
|
F
|
FIH Mobile Ltd
OTC:FXCNY
|
CN |
|
Moberg Pharma AB (publ)
STO:MOB
|
SE |
Corteva Inc (0A1W)’s 12-month stock price forecast through November 2027 has a consensus target of €15.56, implying 49% upside. The forecast is based on price targets from 23 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
0A1W is 15.56 EUR with a low forecast of 12.37 EUR and a high forecast of 95.16 EUR.
Over the last 8 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 5 years is 3%.
Over the last 8 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 5 years is 5%.
Over the last 8 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 5 years is 9%.
The compound annual growth rate for Pre-Tax Income over the next 3 years is -16%.
Over the last 8 years, the compound annual growth rate for Net Income has been -10%. The projected CAGR for the next 5 years is 22%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more